We are pleased to announce that the Chemical Proteomics Platform at IMol is now open.
The Chemical Proteomics Platform offers advanced experimental and analytical tools to support drug development by studying how small molecules interact with proteins.
By combining probe-based and label-free methods, the platform enables direct detection and quantification of protein–molecule interactions in living cells or complex biological samples. It provides access to advanced services for academic and business users, accelerating drug development and supporting small-molecule research.
Now available as a service for external users, the platform provides expert guidance at every stage – from experimental design to data analysis – helping researchers accelerate the drug discovery and development process.
More information is available on the Proteomics Core Facility webpage